Ocular Therapeutix Inc. OCUL
$8.96
▲ +2.76% 24H
About
Ocular Therapeutix Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for diseases and conditions of the eye. It specializes in ophthalmology, particularly advancing treatments for retinal disorders such as wet age-related macular degeneration (wet AMD) and non-proliferat…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees274
TickerOCUL
Statistics
Market Cap$1.96B
Revenue (TTM)$52.0M
Net Income-$265.9M
Net Margin-511.9%
EPS$-1.42
P/E-6.14
P/S34.33
P/B2.69
EV/EBITDA-4.13
ROE-68.6%
Dividend Yield—
Price$8.96
Data: Twelve Data · Revenue = mcap / P/S